Sanofi to Halt MRNA Covid-19 Vaccine Development
28 Septiembre 2021 - 03:28AM
Noticias Dow Jones
By Cecilia Butini
Sanofi SA said Tuesday that it won't further advance the
development of a messenger-RNA vaccine against Covid-19 and would
instead focus on another type of shot, based on recombinant protein
technology.
The French pharma major said it wouldn't make sense for it to
advance its mRNA vaccine into a phase 3 trial, despite previously
announcing positive results from a phase 1/2 trial.
"From a public-health perspective, mRNA Covid vaccines are
widely available today and starting a placebo-controlled study in
countries where vaccines are available would be extremely
challenging," a company spokesman said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
September 28, 2021 04:13 ET (08:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024